Nina Herne

This inventor holds 10 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Affibody Ab, General Electric Company. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nina Herne. Retrieved from https://idiyas.com/inventor/nina-herne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 6)

% Patents Active = 90.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 42(Granted Patents)

Company Filing History:

General Electric Company

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653913 - HER2 BINDERS (2026-06-16),

2. 11633507 - HER2 binders (2023-04-25),

3. 10894097 - HER2 binders (2021-01-19),

4. 10556933 - Polypeptide libraries with a predetermined scaffold (2020-02-11),

5. 10159760 - HER2 binders (2018-12-25),

6. 9469670 - Polypeptide libraries with a predetermined scaffold (2016-10-18),

7. 8883120 - Polypeptides having affinity for HER2 (2014-11-11),

8. 8642743 - Method for reducing the immune response to a biologically active protein (2014-02-04),

9. 8501909 - Polypeptides having affinity for HER2 (2013-08-06),

10. 7993848 - Staphylococcus protein A domain mutants that bind to TNF-α (2011-08-09),

Title: Inventor Spotlight: Nina Herne

Introduction

Nina Herne, an accomplished inventor based in Stockholm, Sweden, has made significant contributions to the field of biotechnology. With an impressive portfolio of nine patents, her work primarily revolves around innovative imaging agents that target specific proteins.

Latest Patents

Nina's latest patents include HER2 binders, which consist of imaging agents that feature an isolated polypeptide conjugated with a radionuclide and a chelator. These agents are designed to specifically bind to HER2 or its variants, providing crucial methods for preparing and utilizing these imaging agents in medical diagnostics.

Career Highlights

Throughout her career, Nina has worked with reputable companies such as Affibody AB and General Electric Company. Her experience in these organizations highlights her expertise in developing groundbreaking technologies that bridge the gap between molecular biology and medical imaging.

Collaborations

Nina has collaborated with notable colleagues such as Joachim Feldwisch and Christofer Lendel. Together, they have advanced the understanding and application of imaging techniques that hold great promise for early disease detection and treatment monitoring.

Conclusion

Nina Herne's innovative spirit and dedication to her work have positioned her as a notable figure in the biotechnology industry. Her patents not only reflect her ingenuity but also contribute to advancements that could reshape medical imaging and therapeutic applications. Her ongoing commitment to innovation promises to yield even more significant breakthroughs in the future.

Profile summary based on public USPTO records.